The Effect of Prinomastat (AG3340), a Synthetic Inhibitor of Matrix Metalloproteinases, on Posttraumatic Proliferative Vitreoretinopathy

By  

Ophthalmic Research, Vol. 33, Iss. 1, 2000-12 ,pp. : 20-23

Karger

Access to resources Recommend Favorite

The effect of prinomastat (AG3340), a synthetic inhibitor of matrix metalloproteinases, on uveal melanoma rabbit model

By Ozerdem Ugur   Mach-Hofacre Beata   Varki Nissi   Folberg Robert   Mueller Arthur J.   Ochabski Renata   Pham Tony   Appelt Krzysztof   Freeman William R.  

Current Eye Research, Vol. 24, Iss. 2, 2002-02 ,pp. : 86-91

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of Prinomastat® (AG3340), a matrix metalloprotease inhibitor, in treatment of retinal neovascularization

By Garcia Claudio R.   Bartsch Dirk-Uwe   Rivero Maria E.   Hagedorn Martin   McDermott Charles D.   Bergeron-Lynn Germaine   Cheng Lingyun   Appelt Krzysztof   Freeman William R.  

Current Eye Research, Vol. 24, Iss. 1, 2002-01 ,pp. : 33-38

Informa Healthcare

Access to resources Recommend Favorite

Porcine model of proliferative vitreoretinopathy with platelets

By García-Layana Alfredo   Pastor J. Carlos   Saornil M. Antonia   Gonzalez Gloria  

Current Eye Research, Vol. 16, Iss. 6, 1997-06 ,pp. : 556-563

Informa Healthcare

Access to resources Recommend Favorite

The role of retinotomy in an experimental rabbit model of proliferative vitreoretinopathy

By Goldaracena M. Begoña   Garcia-Layana Alfredo   Pastor J. Carlos   Saornil María A.   de la Fuente Francisco   Gayoso Manuel J.  

Current Eye Research, Vol. 16, Iss. 5, 1997-05 ,pp. : 422-427

Informa Healthcare

Access to resources Recommend Favorite